Immunomedics
| Use attributes for filter ! | |
| Headquarters | Morris Plains |
|---|---|
| New Jersey | |
| United States | |
| Founders | David M Goldenberg |
| Founded | 1982 |
| Subsidiaries | Immunomedics GmbH |
| IBC Pharmaceuticals, Inc | |
| Immunomedics, B. V. | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2428514 |
About Immunomedics
Immunomedics is a pharmaceutical company focusing on the development of antibody-drug conjugates for the treatment of cancer. Immunomedics was founded in July 1982 by David M. Goldenberg. Michael Pehl was named CEO in December 2017 but left due to personal reasons in February 2019.
